Ronnett B M, Kurman R J, Zahn C M, Shmookler B M, Jablonski K A, Kass M E, Sugarbaker P H
Division of Gynecologic Pathology, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Hum Pathol. 1995 May;26(5):509-24. doi: 10.1016/0046-8177(95)90247-3.
Pseudomyxoma peritonei (PMP) is a poorly understood condition characterized by the accumulation of abundant mucinous material within the peritoneal cavity and associated with a mucinous tumor of the gastrointestinal tract or ovaries. Recently there has been considerable debate over the primary site of origin of the tumor associated with PMP in women. Some investigators have proposed a primary site in the ovaries, whereas others favor the gastrointestinal tract or the peritoneum. Another confusing issue has been the nature of the ovarian mucinous tumors associated with PMP. Although these neoplasms may be frankly malignant, more often they show minimal cytologic atypia and epithelial proliferation and have been classified as borderline or low malignant potential tumors. In order to address the issues of site of origin and nature of the associated ovarian mucinous tumors, we studied 68 cases of PMP in women, 30 of whom had mucinous tumors involving the ovaries. All 30 of these cases had an associated mucinous appendiceal or intestinal tumor. The PMP cases with ovarian tumors were compared with 30 ovarian mucinous tumors of low malignant potential (LMP). Based on the analysis of the primary ovarian mucinous LMP tumors, a set of criteria was formulated and used to determine the probable site of origin of PMP in the 30 women with mucinous tumors involving the ovaries. The following gross and microscopic features of the ovarian tumor were considered to be inconsistent with a primary ovarian origin: (1) surface involvement with or without superficial stromal involvement only; (2) adenocarcinoma with signet ring cell differentiation, with a previously diagnosed or concurrent appendiceal tumor of similar morphology; (3) bilateral adenocarcinoma consistent with colonic or appendiceal morphology; and (4) unilateral adenocarcinoma consistent with colonic or appendiceal morphology with a history of a colonic or appendiceal adenocarcinoma. When any one of these features was present the ovarian tumor was diagnosed as secondary. The following additional features also were considered to be more typical of secondary ovarian involvement: (1) normal or only slightly enlarged ovaries; (2) bilateral ovarian involvement; (3) simple or only focally proliferative mucinous epithelium with abundant extracellular mucin in cases with predominantly surface involvement of the ovaries, with or without a history of/or concurrent appendiceal adenoma; (4) multifocal or extensive pseudomyxoma ovarii in cases with stromal involvement, with or without a history of/or concurrent appendiceal adenoma; (5) ruptured appendiceal adenoma and unruptured ovarian tumor of similar histology; and (6) presence of an associated mucinous intestinal tumor.(ABSTRACT TRUNCATED AT 400 WORDS)
腹膜假黏液瘤(PMP)是一种了解较少的病症,其特征是腹腔内积聚大量黏液性物质,并与胃肠道或卵巢的黏液性肿瘤相关。最近,关于女性PMP相关肿瘤的原发部位存在相当大的争议。一些研究者提出原发部位在卵巢,而另一些人则倾向于胃肠道或腹膜。另一个令人困惑的问题是与PMP相关的卵巢黏液性肿瘤的性质。尽管这些肿瘤可能是明显恶性的,但更常见的是它们显示出最小的细胞学异型性和上皮增殖,并被归类为交界性或低恶性潜能肿瘤。为了解决起源部位和相关卵巢黏液性肿瘤性质的问题,我们研究了68例女性PMP病例,其中30例有累及卵巢的黏液性肿瘤。所有这30例病例都有相关的黏液性阑尾或肠道肿瘤。将有卵巢肿瘤的PMP病例与30例低恶性潜能(LMP)卵巢黏液性肿瘤进行比较。基于对原发性卵巢黏液性LMP肿瘤的分析,制定了一套标准并用于确定30例有累及卵巢黏液性肿瘤的女性中PMP的可能起源部位。卵巢肿瘤的以下大体和显微镜特征被认为与原发性卵巢起源不一致:(1)仅表面受累,有或无浅表间质受累;(2)印戒细胞分化的腺癌,伴有先前诊断或同时存在的形态相似的阑尾肿瘤;(3)符合结肠或阑尾形态的双侧腺癌;(4)符合结肠或阑尾形态的单侧腺癌,有结肠或阑尾腺癌病史。当出现这些特征中的任何一个时,卵巢肿瘤被诊断为继发性。以下附加特征也被认为更典型地提示继发性卵巢受累:(1)卵巢正常或仅轻微增大;(2)双侧卵巢受累;(3)卵巢主要为表面受累的病例中,单纯或仅局灶性增殖的黏液上皮,伴有大量细胞外黏液,有或无阑尾腺瘤病史/或同时存在阑尾腺瘤;(4)间质受累的病例中,多灶性或广泛性卵巢假黏液瘤,有或无阑尾腺瘤病史/或同时存在阑尾腺瘤;(5)阑尾腺瘤破裂,卵巢肿瘤未破裂,组织学相似;(6)存在相关的黏液性肠道肿瘤。(摘要截断于400字)